Atropine for Myopia Management Made Simple
Instructors.
Jeanne SawAbout this course.
Atropine is the only pharmacological treatment which has shown efficacy across various age groups and ethnicities for myopia control. This Made Simple course has been built to take you through the evidence from 1% to 0.01% for myopia control, for pre-myopia and combination treatment. Step-by-step guidance is provided on clinical care, visual outcomes, side effects, safety, prescribing pathways, clinical communication and resources to provide to parents and carers. Case studies and knowledge checks are included to help you test your learning. More than 70 scientific references have been collated to help you understand how to get started and manage long-term outcomes with atropine for myopia management.
Course Details.
100% Online
Step-by-step guidance
Communication tips
Completion certificate
Self paced learning
Graded quizzes
Accreditation.
Accredited in: United States; Canada
Meet the instructors.
Jeanne is a clinical optometrist based in Sydney, Australia. She has worked as a research assistant with leading vision scientists, and has a keen interest in myopia control and professional education.
As Manager, Professional Affairs and Partnerships, Jeanne works closely with Dr Kate Gifford in developing content and strategy across Myopia Profile's platforms, and in working with industry partners. Jeanne also writes for the CLINICAL domain of MyopiaProfile.com, and the My Kids Vision website, our public awareness platform.
What you will learn.
Chapter 1: Introduction
See the course overview and learning objectives, understand the full picture of myopia control treatments, and download the list of over 70 scientific references.
Chapter 2: The evidence
Understand all the key atropine studies, from 1% to 0.01%, new formulations, pre-myopia and combinations.
Chapter 3: Getting started in practice
A step-by-step guide to prescribing considerations, contraindications, potential visual function impacts, and when to consider combination with an optical treatment.
Chapter 4: Clinical communication
Guidance on explaining atropine mechanisms, monotherapy and combination treatment; tips for ensuring safety, and resources to support patients, parents, you and the practice team.
Chapter 5: Managing long-term outcomes
To ensure safety and efficacy of atropine treatment, a step-by-step guide is provided to long-term management, including key clinical questions and advice on cessation, tapering and managing rebound effects.
Chapter 6: Case studies
Explore two case studies with interactive, guided elements on considering atropine for pre-myopia, and combination treatment for more effective myopia control.
Chapter 7: Test your learning
Ten multiple choice questions to emphasize key points across the course and help you recall the main messages for clinical practice.
Chapter 8: Summary and further learning
Four key take-home messages, with pointers towards further reading, resources and clinical communication tools.
Course Reviews.
4. 65
enriching learning experience
a valuable and enriching experience
Good evidence based studies review
Helpful evidence on the concentrations of atropine used in myopia control and use of monotherapy versus combo therapy.
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.